Streamline your biomarker quantitation with NeuXplore™
Explore our automated solution for high-throughput protein biomarker quantitation
Introducing NeuXplore™
A complete solution for reliable blood based biomarker detection
Proprietary proteomics platform technology
Scalable sample-to-answer Dx system
qPCR analysis software that reports results in pg/mL
Novel technology to detect multiple low-abundance targets
Flexible solutions to enable ultrasensitivity in every lab
Reliable analysis software to report results in pg/mL
As neurodegenerative disease rates rise, the need for rapid, reliable, and accessible diagnostic tools is greater than ever. To answer this need, we have developed NeuXplore, our cost-effective, scalable, sample-to-answer platform. From biomarker validation through clinical diagnostics, our reliable instrument detects ultra-low levels of blood biomarkers, generating trusted results with quantitative outputs (i.e., pg/mL) in less than four hours.
Why choose NeuXplore?
Achieve cost-effective ultrasensitive protein biomarker quantitation with our automated sample-to-answer workflow
Our high-throughput NeuXplore FDA Class II sample-to-answer benchtop instrument, allows for streamlined detection of blood biomarkers in formats of 16, 32, and 48 samples per run.
Simple assay analysis for reliable results
Our proprietary, easy-to-use software processes qPCR data from both benchtop and automated workflows, reporting quantitative, pg/mL blood biomarker panel results.
Superior performance
with a simple, cost-effective workflow
Accurate quantification of protein biomarkers is essential for early diagnosis, effective patient stratification in clinical trials, and efficient clinical research aimed at tackling Alzheimer’s disease (AD). However, gold standard tests often depend on complex, invasive, and costly technologies. A reliable blood-based biomarker test with precise and sensitive quantification capabilities will accelerate breakthroughs, facilitate the development of therapeutics, and significantly improve outcomes.
Taudia is revolutionizing Alzheimer’s disease (AD) diagnostics with a rapid, cost-effective, and fully automated sample-to-answer solution. Our proprietary technology integrates ultrasensitive, accurate quantification with an efficient workflow, delivering results in under four hours. By combining simplicity, flexibility, and scalability, our platform empowers researchers and clinicians to advance AD treatment and enhance patient care.
Don't wait to streamline your protein biomarker research
Contact out team of scientific experts to discuss your biomarker research needs